Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

NCT02349958 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer
Uterine Cancer
Mesotheliomas
Gastrointestinal Cancers
Cervical Cancer

Interventions

DEVICE: HIPEC: MMC 30mg @ T0, 10mg @ T45min
DEVICE: HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0
DEVICE: HIPEC: CDDP 75 mg/m2 @T0
DEVICE: HIPEC: CDDP+ Doxorubicin 50 mg/m2 @T0 15 mg/m2 @T0

Sponsor

Bay Area Gynecology Oncology